Vascepa

fight gloves boxing punch ring tape fists

Pharma

Investor group calls for strategy shift at struggling Amarin

Two "concerned shareholders" are calling for an immediate strategic review at Amarin just two years after the company faced another investor activism.

Zoey Becker Mar 20, 2025 11:00am

Gavel with scales of justice in background

Amarin, after stock crash and layoffs, revives patent lawsuit

Jun 26, 2024 1:01pm

Amarin's CEO resigns, leaving former interim chief to take over

Jun 4, 2024 11:19am

Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

Mar 29, 2024 1:10pm

Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt

Jul 19, 2023 10:45am

After Amarin's clash with Sarissa, CEO Karim Mikhail hits exit

Mar 31, 2023 11:14am